Edgewise Therapeutics Inc’s recent filing unveils that its Officer JOANNE DONOVAN acquired Company’s shares for reported $0.7 million on Jan
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Edgewise Therapeutics
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Edgewise Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $2.74
Edgewise Therapeutics Inc’s recently made public that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $2.74
